Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modern immunosuppression.

D C Cronin1, T W Faust, L Brady

  • 1Section of Transplant Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA.

Clinics in Liver Disease
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory myofibroblastic tumours of the liver - a systematic review.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2024
Same author

Exercise interventions for patients with advanced cancer: A systematic review of recruitment, attrition, and exercise adherence rates.

Palliative & supportive care·2019
Same author

Novel heterozygous mutations in the <i>PGAM2</i> gene with negative exercise testing.

Molecular genetics and metabolism reports·2018
Same author

Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 families.

Clinical genetics·2017
Same author

The effect of whole-brain radiation (WBI) and Karnofsky performance status (KPS) on survival of patients receiving stereotactic radiosurgery (SRS) for second brain metastatic event.

Journal of radiation oncology·2017
Same author

N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.

Journal of thrombosis and haemostasis : JTH·2016

Current posttransplant lymphoproliferative disease (PTLD) treatments involve managing immunosuppression and using antiviral therapy. This article details immunosuppressive agent pharmacology, side effects, and expert treatment strategies for PTLD.

Area of Science:

  • Transplantation immunology
  • Oncology
  • Pharmacology

Background:

  • Posttransplant lymphoproliferative disease (PTLD) is a serious complication following organ or stem cell transplantation.
  • Management of PTLD requires careful balancing of immunosuppression to prevent rejection and control disease.
  • Current strategies include prophylaxis, adjusting immunosuppression, and antiviral therapy.

Purpose of the Study:

  • To describe the pharmacology, pharmacokinetics, side effects, and toxicities of immunosuppressive agents used in PTLD management.
  • To outline current treatment strategies for PTLD.
  • To provide insights into the author's clinical practice regarding immunosuppressive agents and PTLD treatment.

Main Methods:

  • Review of immunosuppressive agents used in PTLD treatment.

Related Experiment Videos

  • Description of pharmacological and pharmacokinetic properties.
  • Discussion of side effects and toxicities.
  • Presentation of clinical practice and treatment strategies.

    • Main Results:

    • Detailed pharmacology and pharmacokinetics of key immunosuppressive drugs.
    • Identification of common and serious side effects and toxicities.
    • Outline of a multi-faceted approach to PTLD treatment, including immunosuppression adjustment and antiviral therapy.
    • Author's specific treatment recommendations and strategies.

    Conclusions:

    • Effective PTLD management necessitates a nuanced approach to immunosuppression.
    • Understanding drug pharmacology and patient-specific factors is crucial for successful treatment.
    • Antiviral therapy plays a role in managing PTLD, particularly in cases with viral evidence.